Deciphering the Nanometabolomics Paradigm: Understanding the Role of Pathophysiology and Biomarkers in Predicting...

Oral cancer represents a significant global health burden, with its incidence steadily increasing over recent years. Despite advancements in treatment modalities, early diagnosis and effective therapeutic strategies remain elusive, necessitating innovative approaches. Metabolomics, a powerful analytical technique, offers insights into the metabolic alterations associated with oral cancer progression. By profiling metabolites, it enables the identification of biomarkers indicative of disease onset, progression, and response to treatment.

Nanotechnology emerges as a promising ally in overcoming these limitations. Nanomaterials possess unique physicochemical properties that can be harnessed for targeted drug delivery, imaging, and sensing. In this context, our aim is to summarize implication of nanotechnology-integrated metabolomics as facilitators for the development of novel diagnostic platforms and therapeutics with enhanced specificity and efficacy. To address this, our objectives are segregated wherein the metabolomics profiling of biomarkers was investigated contributing to the diagnosis and prognosis of oral cancers. The implication of nanotechnology insights targeted molecular imaging, biomarker analysis and nano-omics technological adavancements assisting early prognosis of oral cancer. In summary, comprehensive literature review of exploring the metabolomic profiling coupled with nanomaterial-based intervention enables early detection of oral cancer with unprecedented sensitivity and specificity.

This review comprehensively discusses recent advancements in metabolomic profiling and nanotechnology-based approaches for oral cancer diagnosis and treatment. Advanced technology and biological instruments present excellent prospects for metabolic profiling, enabling the identification of biomarkers for early identification, prognosis, and consequently planned and comprehensive therapy that would be most advantageous for the patients. Amalgamating the skills of physicians, researchers, and bioinformatics will undoubtedly aid in overcoming obstacles and enable patients with oral cancer to fully benefit from metabolism when receiving precision oncology treatment.